Lytix Biopharma AS (OSL:LYTIX)
Norway · Delayed Price · Currency is NOK 8.90
-0.08 (-0.89%)
Aug 1, 2025, 4:25 PM CET
Lytix Biopharma AS Market Cap
Lytix Biopharma AS has a market cap or net worth of 607.53 million as of August 1, 2025. Its market cap has increased by 34.57% in one year.
Market Cap
607.53M
Enterprise Value
492.51M
Revenue
608.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
8.90
Market Cap Chart
Since June 14, 2021, Lytix Biopharma AS's market cap has decreased from 720.55M to 607.53M, a decrease of -15.68%. That is a compound annual growth rate of -4.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 607.53M | 51.36% |
| Dec 30, 2024 | 401.38M | 106.12% |
| Dec 29, 2023 | 194.73M | -37.37% |
| Dec 30, 2022 | 310.93M | -41.63% |
| Dec 30, 2021 | 532.66M | -26.08% |
| Jun 14, 2021 | 720.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.18B |
| Nordhealth AS | 3.04B |
| Photocure ASA | 1.68B |
| Vistin Pharma ASA | 1.08B |
| Omda AS | 1.04B |
| ArcticZymes Technologies ASA | 939.71M |
| Gentian Diagnostics ASA | 913.00M |
| Thor Medical ASA | 870.72M |